Related references
Note: Only part of the references are listed.Glioblastoma, Cancer Stem Cells and Hypoxia
Eli E. Bar
BRAIN PATHOLOGY (2011)
HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PIGF
Charlotte Rolny et al.
CANCER CELL (2011)
Glioblastoma Recurrence after Cediranib Therapy in Patients: Lack of Rebound Revascularization as Mode of Escape
Emmanuelle di Tomaso et al.
CANCER RESEARCH (2011)
CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model
Saima Hassan et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Tumor-Induced Endothelial Cell Apoptosis: Roles of NAD(P)H Oxidase-Derived Reactive Oxygen Species
Ruei-Zeng Lin et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Disease Course Patterns After Discontinuation of Bevacizumab: Pooled Analysis of Randomized Phase III Trials
David Miles et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08
Carmen J. Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Mechanisms of Disease: Hypoxia and Inflammation.
Holger K. Eltzschig et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells
Sachie Hiratsuka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation
Sachie Hiratsuka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Transdifferentiation of glioblastoma cells into vascular endothelial cells
Yasushi Soda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The role of the organ microenvironment in brain metastasis
Isaiah J. Fidler
SEMINARS IN CANCER BIOLOGY (2011)
Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)
M. Reck et al.
ANNALS OF ONCOLOGY (2010)
Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials
A. Valachis et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Hypoxia inducible factors in cancer stem cells
J. M. Heddleston et al.
BRITISH JOURNAL OF CANCER (2010)
Double Antiangiogenic Protein, DAAP, Targeting VEGF-A and Angiopoietins in Tumor Angiogenesis, Metastasis, and Vascular Leakage
Young Jun Koh et al.
CANCER CELL (2010)
Anti-Placental Growth Factor Reduces Bone Metastasis by Blocking Tumor Cell Engraftment and Osteoclast Differentiation
Lieve Coenegrachts et al.
CANCER RESEARCH (2010)
Differential Effects of VEGFR-1 and VEGFR-2 Inhibition on Tumor Metastases Based on Host Organ Environment
Yoon-Jin Lee et al.
CANCER RESEARCH (2010)
Suppression of Tumor Growth and Metastasis by Simultaneously Blocking Vascular Endothelial Growth Factor (VEGF)-A and VEGF-C with a Receptor-Immunoglobulin Fusion Protein
Dapeng Zhang et al.
CANCER RESEARCH (2010)
Cediranib/AZD2171 Inhibits Bone and Brain Metastasis in a Preclinical Model of Advanced Prostate Cancer
Juan Juan Yin et al.
CANCER RESEARCH (2010)
PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth
Carlos Bais et al.
CELL (2010)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
Hypoxia induces PTHrP gene transcription in human cancer cells through the HIF-2α
Michal Manisterski et al.
CELL CYCLE (2010)
HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells Autophagy drives compartment-specific oncogenesis
Barbara Chiavarina et al.
CELL CYCLE (2010)
Oxygen in Stem Cell Biology: A Critical Component of the Stem Cell Niche
Ahmed Mohyeldin et al.
CELL STEM CELL (2010)
Effects of Anti-VEGF Treatment Duration on Tumor Growth, Tumor Regrowth, and Treatment Efficacy
Anil Bagri et al.
CLINICAL CANCER RESEARCH (2010)
Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
Wei Zhang et al.
CLINICAL CANCER RESEARCH (2010)
Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis
Xin Lu et al.
CLINICAL CANCER RESEARCH (2010)
HIF-1: upstream and downstream of cancer metabolism
Gregg L. Semenza
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
Cancer Dissemination-Lessons from Leukocytes
Chris D. Madsen et al.
DEVELOPMENTAL CELL (2010)
VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop
Oscar Gonzalez-Moreno et al.
EXPERIMENTAL CELL RESEARCH (2010)
Retention of prolyl hydroxylase PHD2 in the cytoplasm prevents PHD2-induced anchorage-independent carcinoma cell growth
Terhi Jokilehto et al.
EXPERIMENTAL CELL RESEARCH (2010)
Combination Therapy of Interleukin-2 and Sorafenib Improves Survival Benefits and Prevents Spontaneous Pulmonary Metastasis in Murine Renal Cell Carcinoma Models
Yosuke Amagai et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
The role of HIF prolyl hydroxylases in tumour growth
Terhi Jokilehto et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Hypoxia-inducible factor 2α regulates macrophage function in mouse models of acute and tumor inflammation
Hongxia Z. Imtiyaz et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival
Bernard Escudier et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Mechanisms of Motility in Metastasizing Cells
Mahmut Yilmaz et al.
MOLECULAR CANCER RESEARCH (2010)
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
Amar J. Majmundar et al.
MOLECULAR CELL (2010)
Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2
Roni Mamluk et al.
MABS (2010)
Glioblastoma stem-like cells give rise to tumour endothelium
Rong Wang et al.
NATURE (2010)
Real-time imaging reveals the single steps of brain metastasis formation
Yvonne Kienast et al.
NATURE MEDICINE (2010)
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
G. L. Semenza
ONCOGENE (2010)
Malignant cells facilitate lung metastasis by bringing their own soil
Dan G. Duda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Hypoxia: A Link between Fibrogenesis, Angiogenesis, and Carcinogenesis in Liver Disease
Olivier Rosmorduc et al.
SEMINARS IN LIVER DISEASE (2010)
The Tumor Microenvironment and DNA Repair
Thomas J. Klein et al.
SEMINARS IN RADIATION ONCOLOGY (2010)
Heterogeneity of the Tumor Vasculature
Janice A. Nagy et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)
Suppressive effect of bevacizumab on peritoneal dissemination from gastric cancer in a peritoneal metastasis model
Takuya Imaizumi et al.
SURGERY TODAY (2010)
Metastasis in Melanoma Xenografts Is Associated with Tumor Microvascular Density Rather than Extent of Hypoxia
Einar K. Rofstad et al.
NEOPLASIA (2010)
Bevacizumab Suppression of Establishment of Micrometastases in Experimental Ocular Melanoma
Hua Yang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors
Jason M. Butler et al.
NATURE REVIEWS CANCER (2010)
Endothelial-Mural Cell Signaling in Vascular Development and Angiogenesis
Konstantin Gaengel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Endothelial deletion of hypoxia-inducible factor-2α (HIF-2α) alters vascular function and tumor angiogenesis
Nicolas Skuli et al.
BLOOD (2009)
PTEN suppression of YY1 induces HIF-2 activity in von hippel lindau null renal cell carcinoma
Brenda L. Petrella et al.
CANCER BIOLOGY & THERAPY (2009)
Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
Zhizhong Li et al.
CANCER CELL (2009)
Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche
Janine T. Erler et al.
CANCER CELL (2009)
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M. L. Ebos et al.
CANCER CELL (2009)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
Sunitinib Prolongs Survival in Genetically Engineered Mouse Models of Multistep Lung Carcinogenesis
Leena Gandhi et al.
CANCER PREVENTION RESEARCH (2009)
Direct Evidence that Bevacizumab, an Anti-VEGF Antibody, Up-regulates SDF1α, CXCR4, CXCL6, and Neuropilin 1 in Tumors from Patients with Rectal Cancer
Lei Xu et al.
CANCER RESEARCH (2009)
Pulmonary Vascular Destabilization in the Premetastatic Phase Facilitates Lung Metastasis
Yujie Huang et al.
CANCER RESEARCH (2009)
Tumor Self-Seeding by Circulating Cancer Cells
Mi-Young Kim et al.
CELL (2009)
Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization
Massimiliano Mazzone et al.
CELL (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
VEGF inhibition: insights from preclinical and clinical studies
Yongping Crawford et al.
CELL AND TISSUE RESEARCH (2009)
Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis
M. P. Kim et al.
CELL AND TISSUE RESEARCH (2009)
Hypoxia Helps Glioma to Fight Therapy
Verena Amberger-Murphy
CURRENT CANCER DRUG TARGETS (2009)
The Angiogenic Switch: Implications in the Regulation of Tumor Dormancy
L. Moserle et al.
CURRENT MOLECULAR MEDICINE (2009)
Hypoxia inducible factor-2α: a critical mediator of aggressive tumor phenotypes
Guoliang Qing et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2009)
Kinases as Upstream Regulators of the HIF System: Their Emerging Potential as Anti-Cancer Drug Targets
Elitsa Y. Dimova et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
The Control of Vascular Integrity by Endothelial Cell Junctions: Molecular Basis and Pathological Implications
Elisabetta Dejana et al.
DEVELOPMENTAL CELL (2009)
Regulation of Angiogenesis by Oxygen and Metabolism
Peter Fraisl et al.
DEVELOPMENTAL CELL (2009)
Edema Control by Cediranib, a Vascular Endothelial Growth Factor Receptor-Targeted Kinase Inhibitor, Prolongs Survival Despite Persistent Brain Tumor Growth in Mice
Walid S. Kamoun et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Hypoxia Increases Placenta Growth Factor Expression in Human Myocardium and Cultured Neonatal Rat Cardiomyocytes
Ronald J. Torry et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2009)
New evidence for tumour embolism as a mode of metastasis
Ian R. Hart
JOURNAL OF PATHOLOGY (2009)
Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression
Ulrike Maegdefrau et al.
JOURNAL OF PATHOLOGY (2009)
Effect of Bevacizumab, a Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor, on Peritoneal Metastasis of MNK-45P Human Gastric Cancer in Mice
Shigeo Ninomiya et al.
JOURNAL OF SURGICAL RESEARCH (2009)
Oxygen regulates epithelial-to-mesenchymal transition: insights into molecular mechanisms and relevance to disease
Volker H. Haase
KIDNEY INTERNATIONAL (2009)
Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways
Ymera Pignochino et al.
MOLECULAR CANCER (2009)
Differential effects of the vascular endothelial growth factor receptor inhibitor PTK787/ZK222584 on tumor angiogenesis and tumor lymphangiogenesis
Tibor Schomber et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Zachary T. Schafer et al.
NATURE (2009)
Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system
Hellmut G. Augustin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Collective cell migration in morphogenesis, regeneration and cancer
Peter Friedl et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Antiangiogenic therapies for high-grade glioma
Andrew D. Norden et al.
NATURE REVIEWS NEUROLOGY (2009)
Hyperoxic Treatment Induces Mesenchymal-to-Epithelial Transition in a Rat Adenocarcinoma Model
Ingrid Moen et al.
PLOS ONE (2009)
In Vivo Antitumor and Antimetastatic Activity of Sunitinib in Preclinical Neuroblastoma Mouse Model
Libo Zhang et al.
NEOPLASIA (2009)
Metastasis: from dissemination to organ-specific colonization
Don X. Nguyen et al.
NATURE REVIEWS CANCER (2009)
Microenvironmental regulation of metastasis
Johanna A. Joyce et al.
NATURE REVIEWS CANCER (2009)
Hypoxia-inducible factor-1 alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients
Galatea Kallergi et al.
BREAST CANCER RESEARCH (2009)
The role of metastasis, suppressor genes in metastatic dormancy
Christine E. Horak et al.
APMIS (2008)
HIF1α induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion
Rose Du et al.
CANCER CELL (2008)
Targeting angiogenesis driven by vascular endothelial growth factors using antibody-based therapies
Axel Grothey et al.
CANCER JOURNAL (2008)
Tube travel: The role of proteases in individual and collective a cancer cell invasion
Peter Friedl et al.
CANCER RESEARCH (2008)
Hypoxia-inducible Factor 1α Mediates Anoikis Resistance via Suppression of α5 Integrin
Nadine Rohwer et al.
CANCER RESEARCH (2008)
TGFβ primes breast tumors for lung metastasis seeding through angiopoietin-like 4
David Padua et al.
CELL (2008)
Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase
Junji Matsui et al.
CLINICAL CANCER RESEARCH (2008)
Hungry for blood vessels: Linking metabolism and angiogenesis
Peter Fraisl et al.
DEVELOPMENTAL CELL (2008)
Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes
Sven A. Lang et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib
Timothy P. Padera et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway
William G. Kaelin et al.
MOLECULAR CELL (2008)
Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis
Dingcheng Gao et al.
SCIENCE (2008)
Pericytes: gatekeepers in tumour cell metastasis?
Holger Gerhardt et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?
Christian Fischer et al.
NATURE REVIEWS CANCER (2008)
Modes of resistance to anti-angiogenic therapy
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2008)
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Kathy Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells
Cedric Gaggioli et al.
NATURE CELL BIOLOGY (2007)
Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model
Brandt Whitehurst et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Models, mechanisms and clinical evidence for cancer dormancy
Julio A. Aguirre-Ghiso
NATURE REVIEWS CANCER (2007)
Tie2-expressing monocytes and tumor angiogenesis: Regulation by hypoxia and angiopoletin-2
Claire E. Lewis et al.
CANCER RESEARCH (2007)
Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer
Aleksandra Franovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma
Xiong-Zhi Wu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Vascular endothelial growth factor trap blocks tumor growth, metastasis formation, and vascular leakage in an orthotopic murine renal cell cancer model
Henk M. W. Verheul et al.
CLINICAL CANCER RESEARCH (2007)
A perivascular niche for brain tumor stem cells
Christopher Calabrese et al.
CANCER CELL (2007)
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
Tracy T. Batchelor et al.
CANCER CELL (2007)
Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion
David Zagzag et al.
LABORATORY INVESTIGATION (2006)
Lysyl oxidase mediates hypoxic control of metastasis
Janine T. Erler et al.
CANCER RESEARCH (2006)
Rapid vascular regrowth in tumors after reversal of VEGF inhibition
Michael R. Mancuso et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1α protein by recruiting histone deacetylase 1
YG Yoo et al.
EMBO JOURNAL (2006)
The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation
B Bedogni et al.
CANCER CELL (2005)
Vascular endothelial growth factor trap combined with paclitaxel strikingly inhibits tumor and ascites, prolonging survival in a human ovarian cancer model
LM Hu et al.
CLINICAL CANCER RESEARCH (2005)
Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity
BJ Moeller et al.
CANCER CELL (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Hypoxia induces adhesion molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates
T Koike et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The hypoxic response of tumors is dependent on their microenvironment
B Blouw et al.
CANCER CELL (2003)
Regression of established tumors and metastases by potent vascular endothelial growth factor blockade
JZ Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma
S Le Jan et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis
E Olaso et al.
HEPATOLOGY (2003)
Evaluation of vascular endothelial growth factor blockade and matrix metalloproteinase inhibition as a combination therapy for experimental human pancreatic cancer
HG Hotz et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2003)
Suppression of primary tumor growth in a mouse model of human neuroblastoma
DH Rowe et al.
JOURNAL OF PEDIATRIC SURGERY (2000)
Anti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms' tumor
DH Rowe et al.
JOURNAL OF PEDIATRIC SURGERY (2000)
Share Paper
